参考文献/References:
[1] JAKOBS T C,LIBBY R T,BEN Y,JOHN S W,MASLAND R H.Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice[J].J Cell Biol,2005,171(2):313-325.
[2] BUCKINGHAM B P,INMAN D M,LAMBERT W,OGLESBY E,CALKINS D J,STEELE M R,et al.Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma[J].J Neurosci,2008,28(11):2735-2744.
[3] SOTO I,OGLESBY E,BUCKINGHAM B P,SON J L,ROBERSON E D,STEELE M R,et al.Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model[J].J Neurosci,2008,28(2):548-561.
[4] GUO Y,JOHNSON E C,CEPURNA W O,DYCK J A,DOSER T,MORRISON J C.Early gene expression changes in the retinal ganglion cell layer of a rat glaucoma model[J].Invest Ophthalmol Vis Sci,2011,52(3):1460-1473.
[5] PANAGIS L,ZHAO X,GE Y,REN L,MITTAG T W,DANIAS J.Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice[J].Invest Ophthalmol Vis Sci,2010,51(4):2024-2034.
[6] WANG D Y,RAY A,RODGERS K,ERGORUL C,HYMAN B T,HUANG W,et al.Global gene expression changes in rat retinal ganglion cells in experimental glaucoma[J].Invest Ophthalmol Vis Sci,2010,51(8):4084-4095.
[7] BADEA T C,WILLIAMS J,SMALLWOOD P,SHI M,MOTAJO O,NATHANS J.Combinatorial expression of Brn3 transcription factors in somatosensory neurons:genetic and morphologic analysis[J].J Neurosci,2012,32(3):995-1007.
[8] SAJGO S,ALI S,POPESCU O,BADEA T C.Dynamic expression of transcription factor Brn3b during mouse cranial nerve development[J].J Comp Neurol,2016,524(5):1033-1061.
[9] GAN L,XIANG M,ZHOU L,WAGNER D S,KLEIN W H,NATHANS J.POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells[J].Proc Natl Acad Sci U S A,1996,93(9):3920-3925.
[10] GAN L,WANG S W,HUANG Z,KLEIN W H.POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification[J].Dev Biol,1999,210(2):469-480.
[11] WU F,KACZYNSKI T J,SETHURAMANUJAM S,et al.Two transcription factors,Pou4f2 and Isl1,are sufficient to specify the retinal ganglion cell fate[J].Proc Natl Acad Sci U S A,2015,112(13):E1559-1568.
[12] STANKOWSKA D L,MINTON A Z,RUTLEDGE M A,MUELLER B H,PHATAK N R,HE S,et al.Neuroprotective effects of transcription factor brn3b in an ocular hypertension rat model of glaucoma[J].Invest Ophthalmol Vis Sci,2015,56(2):893-907.
[13] PHATAK N R,STANKOWSKA D L,KRISHNAMOORTHY R R.Bcl-2,Bcl-xL,and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma[J].Mol Vis,2016,22:1048-1061.
[14] ZHOU Y,PERNET V,HAUSWIRTH W W,DI P A.Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma[J].Mol Ther,2005,12(3):402-412.
[15] HUANG L,HU F,XIE X,HARDER J,FERNANDES K,ZENG X Y,et al.Pou4f1 and pou4f2 are dispensable for the long-term survival of adult retinal ganglion cells in mice[J].PLoS One,2014,9(4):941-973.
[16] SANCHEZMIGALLON M C,VALIENTESORIANO F J,NADALNICOLAS F M,VIDALSANZ M,AGUDOBARRIUSO M.Apoptotic retinal ganglion cell death after optic nerve transection or crush in mice:delayed RGC loss with BDNF or a caspase 3 inhibitor[J].Invest Ophthalmol Vis Sci,2016,57(1):81-93.
[17] BALTMR A,DUGGAN J,NIZARI S,SALT T E,CORDEIRO MF.Neuroprotection in glaucoma-Is there a future role?[J].Exp Eye Res,2010,91(5):554-566.
[18] GHINIA M G,NOVELLI E,SAJGO S,BADEA T C,STRETTOIi E.Brn3a and Brn3b knock-out mice display unvaried retinal fine structure despite major morphological and numerical alterations of ganglion cells[J].J Comp Neurol,2016.
[19] ASHTARI M,CYCKOWSKI L L,MONROE J F,MARSHALL K A,CHUNG D C,AURICCHIO A,et al.The human visual cortex responds to gene therapy-mediated recovery of retinal function[J].J Clin Invest,2011,121(6):2160-2168.
[20] BAINBRIDGE J W,SMITH A J,BARKER S S,ROBBIE S,HENDERSON R,BALAGGAN K,et al.Effect of gene therapy on visual function in Leber’s congenital amaurosis[J].N Engl J Med,2008,358(21):2231-2239.
[21] BENNETT J,ASHTARI M,WELLMAN J,MARSHAL K A,CYCKOWSKI L L,CHUNG D C,et al.AAV2 gene therapy readministration in three adults with congenital blindness[J].Sci Transl Med,2012,4(120):120-135.
[22] MAGUIRE A M,SIMONELLI F,PIERCE E A,PUGH E N JR,MINGOZZI F,BENNICELLI J,et al.Safety and efficacy of gene transfer for Leber’s congenital amaurosis[J].N Engl J Med,2008,358(21):2240-2248.
[23] TYRNER E E,JENNE K J,ROSENFELD M G.Brn-3.2:a Brn-3-related transcription factor with distinctive central nervous system expression and regulation by retinoic acid[J].Neuron,1994,12(1):205-218.
[24] NASKAR R,THANOS S.Retinal gene profiling in a hereditary rodent model of elevated intraocular pressure[J].Mol Vis,2006,12:199-210.
[25] SOTO I,OGLESBY E,BUCKINGHAM B P,SON J L,ROBERSON E D O,STEELE M R,et al.Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model[J].J Neurosci,2008,28(2):548-561.
[26] WEISHAUPT J H,KLOCKER N,BAHR M.Axotomy-induced early down-regulation of POU-IV class transcription factors Brn-3a and Brn-3b in retinal ganglion cells[J].J Mol Neurosci,2005,26(1):17-25.
[27] BUDHRAM-MAHADEO V S,BOWEN S,LEE S,PEREZ-SAN-CHEZ C,ENSOR E,MORRIS P J,et al.Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression[J].Nucleic Acids Res,2006,34(22):6640-6652.
[28] ERKMAN L,YATESA P A,MCLAUGHLIN T,MCEVILLY R J,WHISENHUNT T,O’CONNELL S M,et al.A POU domain transcription factor-dependent program regulates axon pathfinding in the vertebrate visual system[J].Neuron,2000,28(3):779-792.
[29] WANG S W,GAN L,MARTIN S E,KLEIN W H.Abnormal polarization and axon outgrowth in retinal ganglion cells lacking the POU-domain transcription factor Brn-3b[J].Mol Cell Neurosci,2000,16(2):141-156.
[30] QIU F,JIANG H,XIANG M.A comprehensive negative regulatory program controlled by Brn3b to ensure ganglion cell specification from multipotential retinal precursors[J].J Neurosci,2008,28(13):3392-3403.
相似文献/References:
[1]喻小龙 谭钢 刘二华 周寿红.罗格列酮对高糖诱导视网膜神经节细胞损伤的保护作用[J].眼科新进展,2013,33(2):000.
[2]梁静 万新顺.川芎嗪对慢性高眼压大鼠视网膜神经节细胞凋亡的影响[J].眼科新进展,2013,33(8):000.
[3]唐大川 杨红.壳聚糖对分层及纯化培养的视网膜神经节细胞生长的促进作用[J].眼科新进展,2012,32(8):000.
[4]卢艳 董海莲 张丽娜 王蓉.淀粉样前体蛋白转基因痴呆模型小鼠视网膜和视神经纤维层病理改变[J].眼科新进展,2012,32(9):000.
[5]魏欣 陈晓明 佘春燕 李妮 霍朝奎 刘旭阳.聚苯乙烯微球前房注射诱导小鼠高眼压模型[J].眼科新进展,2013,33(3):000.
[6]陈莲 石晶明.青光眼患者视网膜神经节细胞凋亡机制的研究进展[J].眼科新进展,2013,33(4):000.
[7]何小娟 周卫为 张庆平 谭少健 梁皓 张鸿侃.前列地尔对体外培养类缺血再灌注损伤模型视网膜神经节细胞的影响[J].眼科新进展,2013,33(5):000.
[8]陈歆雅 张圣海 吴继红.表观遗传对视网膜神经节细胞发育及凋亡的调控[J].眼科新进展,2013,33(10):000.
[9]刘晓坤 张晓宇 王赟 赵平.米诺环素对大鼠视神经挫伤后视网膜Caspase-3表达的影响[J].眼科新进展,2013,33(12):000.
[10]杜然然 毕宏生 郭俊国 王兴荣 郭大东 田庆梅. 枸杞多糖对体外培养视网膜神经节细胞的保护作用[J].眼科新进展,2014,34(2):119.